کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2514623 1118475 2008 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors
موضوعات مرتبط
علوم پزشکی و سلامت داروسازی، سم شناسی و علوم دارویی داروشناسی
پیش نمایش صفحه اول مقاله
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors
چکیده انگلیسی

The present study was designed to perform binding and thermodynamic characterization of human P2X1 and P2X3 purinergic receptors expressed in HEK 293 cells. The thermodynamic parameters ΔG°, ΔH° and ΔS° (standard free energy, enthalpy and entropy) of the binding equilibrium of well-known purinergic agonists and antagonists at P2X1 and P2X3 receptors were determined. Saturation binding experiments, performed in the temperature range 4–30 °C by using the high affinity purinergic agonist [3H]αβmeATP, revealed a single class of binding sites with an affinity value in the nanomolar range in both cell lines examined. The affinity changed with the temperature whereas receptor density was essentially independent of it. van’t Hoff plots of the purinergic receptors were linear in the range 4–30 °C for agonists and antagonists. The thermodynamic parameters of the P2X1 or P2X3 purinergic receptors were in the ranges −31 kJ mol−1 ≤ ΔH° ≤ −19 kJ mol−1 and 17 J K−1 mol−1 ≤ ΔS° ≤ 51 J K−1 mol−1 or −26 kJ mol−1 ≤ ΔH° ≤ 36 kJ mol−1 and 59 ≤ ΔS° ≤ 249 J K−1 mol−1, respectively. The results of these parameters showed that P2X1 receptors are not thermodynamically discriminated and that the binding of agonists and antagonists was both enthalpy and entropy-driven. P2X3 receptors were thermodynamically discriminated and purinergic agonist binding was enthalpy and entropy-driven while antagonist binding was totally entropy-driven. The analysis of such thermodynamic data makes it possible to obtain additional information on the nature of the forces driving the purinergic binding interaction. These data could be interesting in drug discovery programs aimed at development of novel and potent P2X1 and P2X3 purinergic ligands.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biochemical Pharmacology - Volume 75, Issue 5, 1 March 2008, Pages 1198–1208
نویسندگان
, , , , , , ,